BMJ Best Practice

参考文献

关键文献

Nowak DA, Fink GR. Psychogenic movement disorders: aetiology, phenomenology, neuroanatomical correlates and therapeutic approaches. Neuroimage. 2009;47:1015-1025.

Baslet G. Psychogenic non-epileptic seizures: a model of their pathogenic mechanism. Seizure. 2011;20:1-13.

Reuber M. The etiology of psychogenic non-epileptic seizures: toward a biopsychosocial model. Neurol Clin. 2009;27:909-924.

Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008;37:339-352.

Kleinstauber M, Witthöft M, Hiller W. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev. 2011;31:146-160.

Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69:881-888.

Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369:946-955.

Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med. 2007;69:889-900.

参考文章

1.  American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.

2.  American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV, 4th ed. Washington, DC: American Psychiatric Association; 1994.

3.  Stone J, Zeman A, Sharpe M. Functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2002;73:241-245.

4.  Binzer M, Andersen PM, Kullgren G. Clinical characteristics of patients with motor disability due to conversion disorder: a prospective control group study. J Neurol Neurosurg Psychiatry. 1997;63:83-88.

5.  Ford CV, Folks DG. Conversion disorders: an overview. Psychosomatics. 1985;26:371-374, 380-383.

6.  Lazare A. Current concepts in psychiatry: conversion symptoms. N Engl J Med. 1981;305:745-748.

7.  McKenzie PS, Oto M, Graham CD, et al. Do patients whose psychogenic non-epileptic seizures resolve, 'replace' them with other medically unexplained symptoms? Medically unexplained symptoms arising after a diagnosis of psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry. 2011;82:967-969.

8.  Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001;16:266-275.

9.  Tomasson K, Kent D, Coryell W. Somatization and conversion disorders: comorbidity and demographics at presentation. Acta Psychiatr Scand. 1991;84:288-293.

10.  Guz H, Doganay Z, Ozkan A, et al. Conversion and somatization disorders: dissociative symptoms and other characteristics. J Psychosom Res. 2004;56:287-291.

11.  Akagi J, House A. The epidemiology of hysterical conversion. In: Halligan PW, Bass CM, Marshall JC, eds. Contemporary approaches to the study of hysteria. Oxford, UK: Oxford University Press; 2001:73-87.

12.  Carson AJ, Ringbauer B, Stone J, et al. Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry. 2000;68:207-210.

13.  Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry. 1995;59:406-412.

14.  Benbadis SR, Allen Hauser W. An estimate of the prevalence of psychogenic non-epileptic seizures. Seizure. 2000;9:280-281.

15.  Krumholz A, Ting T. Coexisting epilepsy and nonepileptic seizures. In: Kaplan PW, Fisher RS, eds. Imitators of epilepsy. New York, NY: Demos Medical Publishing; 2005:261-276.

16.  Kozlowska K, Nunn KP, Rose D, et al. Conversion disorder in Australian pediatric practice. J Am Acad Child Adolesc Psychiatry. 2007;46:68-75.

17.  Stone J, Smyth R, Carson A, et al. Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ. 2005;331:989.

18.  Stonnington CM, Locke DE, Hsu CH, et al. Somatization is associated with deficits in affective theory of mind. J Psychosom Res. 2013;74:479-485.

19.  Katon W, Kleinman A, Rosen G. Depression and somatization: a review: part I. Am J Med. 1982;72:127-135.

20.  Noyes R Jr, Holt CS, Kathol RG. Somatization: diagnosis and management. Arch Fam Med. 1995;4:790-795.

21.  Brown RJ. The cognitive psychology of dissociative states. Cogn Neuropsychiatry. 2002;7:221-235.

22.  Brown RJ, Cardena E, Nijenhuis E, et al. Should conversion disorder be reclassified as a dissociative disorder in DSM V? Psychosomatics. 2007;48:369-378.

23.  Nowak DA, Fink GR. Psychogenic movement disorders: aetiology, phenomenology, neuroanatomical correlates and therapeutic approaches. Neuroimage. 2009;47:1015-1025.

24.  Baslet G. Psychogenic non-epileptic seizures: a model of their pathogenic mechanism. Seizure. 2011;20:1-13.

25.  Black DN, Seritan AL, Taber KH, et al. Conversion hysteria: lessons from functional imaging. J Neuropsychiatry Clin Neurosci. 2004;16:245-251.

26.  Voon V, Brezing C, Gallea C, et al. Emotional stimuli and motor conversion disorder. Brain. 2010;133:1526-1536.

27.  van der Kruijs SJ, Bodde NM, Vaessen MJ, et al. Functional connectivity of dissociation in patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry. 2012;83:239-247.

28.  Cojan Y, Waber L, Carruzzo A, et al. Motor inhibition in hysterical conversion paralysis. Neuroimage. 2009;47:1026-1037.

29.  Ejareh Dar M, Kanaan RA. Uncovering the etiology of conversion disorder: insights from functional neuroimaging. Neuropsychiatr Dis Treat. 2016;12:143-153.

30.  Voon V, Gallea C, Hattori N, et al. The involuntary nature of conversion disorder. Neurology. 2010;74:223-228.

31.  Simeon D, Knutelska M, Yehuda R, et al. Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers. Biol Psychiatry. 2007;61:966-973.

32.  Reuber M. The etiology of psychogenic non-epileptic seizures: toward a biopsychosocial model. Neurol Clin. 2009;27:909-924.

33.  Geisser ME, Strader Donnell C, Petzke F, et al. Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Psychosomatics. 2008;49:235-242.

34.  Browning M, Fletcher P, Sharpe M. Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review. Psychosom Med. 2011;73:173-184.

35.  Dimsdale JE, Dantzer R. A biological substrate for somatoform disorders: importance of pathophysiology. Psychosom Med. 2007;69:850-854.

36.  Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21:153-160.

37.  Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008;37:339-352.

38.  Fiszman A, Alves-Leon SV, Nunes RG, et al. Traumatic events and posttraumatic stress disorder in patients with psychogenic nonepileptic seizures: a critical review. Epilepsy Behav. 2004;5:818-825.

39.  Roelofs K, Keijsers GP, Hooqduin KA, et al. Childhood abuse in patients with conversion disorder. Am J Psychiatry. 2002;159:1908-1913.

40.  Spitzer C, Barnow S, Gau K, et al. Childhood maltreatment in patients with somatization disorder. Aust N Z J Psychiatry. 2008;42:335-341.

41.  Schulte IE, Petermann F. Familial risk factors for the development of somatoform symptoms and disorders in children and adolescents: a systematic review. Child Psychiatry Hum Dev. 2011;42:569-583.

42.  Edwards VJ, Holden GW, Felitti VJ, et al. Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am J Psychiatry. 2003;160:1453-1460.

43.  Choi J, Jeong B, Rohan ML, et al. Preliminary evidence for white matter tract abnormalities in young adults exposed to parental verbal abuse. Biol Psychiatry. 2009;65:227-234.

44.  De Gucht V, Heiser W. Alexithymia and somatisation: quantitative review of the literature. J Psychosom Res. 2003;54:425-434.

45.  Mattila AK, Kronholm E, Jula A, et al. Alexithymia and somatization in general population. Psychosom Med. 2008;70:716-722.

46.  De Gucht V. Stability of neuroticism and alexithymia in somatization. Compr Psychiatry. 2003;44:466-471.

47.  Joint Working Group of the Royal College of General Practitioners and the Royal College of Psychiatrists. The management of patients with physical and psychological problems in primary care: a practical guide. January 2009. http://www.rcgp.org.uk/ (last accessed 27 Sep 2016).

48.  van Bokhoven MA, Koch H, van der Weijden T, et al. The effect of watchful waiting compared to immediate test ordering instructions on general practitioners' blood test ordering behaviour for patients with unexplained complaints; a randomized clinical trial (ISRCTN55755886). Implement Sci. 2012;7:29.

49.  Hallet M, Cloninger CR, Fahn S, et al. Psychogenic movement disorders: neurology and neuropsychiatry. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.

50.  Hurwitz TA. Somatization and conversion disorder. Can J Psychiatry. 2004;49:172-178.

51.  Abubakr A, Kablinger A, Caldito G. Psychogenic seizures: clinical features and psychological analysis. Epilepsy Behav. 2003;4:241-245.

52.  Kroenke K, Spitzer RL, Williams JB, et al. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010;32:345-359.

53.  Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale - I: item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38:23-32.

54.  Bagby RM, Taylor GJ, Parker JD. The twenty-item Toronto Alexithymia Scale - II: convergent, discriminant, and concurrent validity. J Psychosom Res. 1994;38:33-40.

55.  Taylor GJ, Bagby RM, Parker JD. The 20-item Toronto Alexithymia Scale - IV: reliability and factorial validity in different languages and cultures. J Psychosom Res. 2003;55:277-283.

56.  Lane RD, Quinlan DM, Schwartz GE, et al. The Levels of Emotional Awareness Scale: a cognitive-developmental measure of emotion. J Pers Assess. 1990;55:124-134.

57.  Binder LM, Campbell KA. Medically unexplained symptoms and neuropsychological assessment. J Clin Exp Neuropsychol. 2004;26:369-392.

58.  Drane DL, Williamson DJ, Stroup ES, et al. Cognitive impairment is not equal in patients with epileptic and psychogenic nonepileptic seizures. Epilepsia. 2006;47:1879-1886.

59.  Locke DE, Berry DT, Fakhoury TA, et al. Relationship of indicators of neuropathology, psychopathology, and effort to neuropsychological results in patients with epilepsy or psychogenic non-epileptic seizures. J Clin Exp Neuropsychol. 2006;28:325-340.

60.  Hathaway SR, McKinley. MMPI-2: Minnesota Multiphasic Personality Inventory-2: manual for administration and scoring. Minneapolis, MN: University of Minnesota Press; 1989.

61.  Morey LC. Personality assessment inventory. Odessa, FL: Psychological Assessment Resources; 1991.

62.  Millon T. Millon Clinical Multiaxial Inventory-II: manual for the MCM-II. Minneapolis, MN: National Computer Systems; 1994.

63.  Cragar DE, Schmitt FA, Berry DT, et al. A comparison of MMPI-2 decision rules in the diagnosis of nonepileptic seizures. J Clin Exp Neuropsychol. 2003;25:793-804.

64.  Schuster JP, Mouchabac S, LeStrat Y, et al. Hysterical mutism. Encephale. 2011;37:339-344.

65.  Salkovskis PM, Rimes KA, Warwick HM, et al. The health anxiety inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002;32:843-853.

66.  van der Feltz-Cornelis CM, Hoedeman R, Keuter EJ, et al. Presentation of the Multidisciplinary Guideline Medically Unexplained Physical Symptoms (MUPS) and Somatoform Disorder in the Netherlands: disease management according to risk profiles. J Psychosom Res. 2012;72:168-169.

67.  Stewart M, Brown JB, Weston WW, et al. Patient-centered medicine: transforming the clinical method. Thousand Oaks, CA: Sage; 1995.

68.  Drane DL, LaRoche SM, Ganesh GA, et al. A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy Behav. 2016;54:34-39.

69.  Goldstein LH, Chalder T, Chigwedere C, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology. 2010;74:1986-1994.

70.  LaFrance WC Jr, Miller IW, Ryan CE, et al. Behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav. 2009;14:591-596.

71.  van Dessel N, den Boeft M, van der Wouden JC, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014;(11):CD011142.

72.  LaFrance WC Jr, Baird GL, Barry JJ, et al; NES Treatment Trial (NEST-T) Consortium. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry. 2014;71:997-1005.

73.  Sharpe M, Walker J, Williams C, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology. 2011;77:564-572.

74.  Hedman E, Axelsson E, Görling A, et al. Internet-delivered exposure-based cognitive-behavioural therapy and behavioural stress management for severe health anxiety: randomised controlled trial. Br J Psychiatry. 2014;205:307-314.

75.  Zonneveld LN, van Rood YR, Timman R, et al. Effective group training for patients with unexplained physical symptoms: a randomized controlled trial with a non-randomized one-year follow-up. PLoS One. 2012;7:e42629 [corrected in: PLoS One. 2013;8].

76.  Fjorback LO. Mindfulness and bodily distress. Dan Med J. 2012;59:B4547.

77.  Fjorback LO, Arendt M, Ornbøl E, et al. Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up. J Psychosom Res. 2013;74:31-40.

78.  Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders: systematic review and meta-analysis of clinical trials. Psychother Psychosom. 2009;78:265-274.

79.  Erceg-Hurn DM. Psychodynamic therapy for somatic disorder meta-analysis raises more questions than answers. Psychother Psychosom. 2011;80:182-183.

80.  Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014;(7):CD004687.

81.  Morriss RK, Dowrick C, Salmon P, et al. Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Br J Psychiatry. 2007;191:536-542.

82.  Mayor R, Howlett S, Grünewald R, et al. Long-term outcome of brief augmented psychodynamic interpersonal therapy for psychogenic nonepileptic seizures: seizure control and health care utilization. Epilepsia. 2010;51:1169-1176.

83.  Sattel H, Lahmann C, Gundel H, et al. Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. Br J Psychiatry. 2012;200:60-67.

84.  Kleinstauber M, Witthöft M, Hiller W. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev. 2011;31:146-160.

85.  Martlew J, Pulman J, Marson AG. Psychological and behavioural treatments for adults with non-epileptic attack disorder. Cochrane Database Syst Rev. 2014;(2):CD006370.

86.  Kisely SR, Campbell LA, Yelland MJ, et al. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database Syst Rev. 2015;(6):CD004101.

87.  Wortman MS, Lucassen PL, van Ravesteijn HJ, et al. Brief multimodal psychosomatic therapy in patients with medically unexplained symptoms: feasibility and treatment effects. Fam Pract. 2016;33:346-353.

88.  Schade N, Torres P, Beyebach M. Cost-efficiency of a brief family intervention for somatoform patients in primary care. Fam Syst Health. 2011;29:197-205.

89.  Griffith JL, Polles A, Griffith ME. Pseudoseizures, families, and unspeakable dilemmas. Psychosomatics. 1998;39:144-153.

90.  Wagner AW, Rizvi SL, Harned MS. Applications of dialectical behavior therapy to the treatment of complex trauma-related problems: when one case formulation does not fit all. J Trauma Stress. 2007;20:391-400.

91.  Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69:881-888.

92.  LaFrance WC Jr, Barry JJ. Update on treatments of psychological nonepileptic seizures. Epilepsy Behav. 2005;7:364-374.

93.  Kleinstäuber M, Witthöft M, Steffanowski A, et al. Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev. 2014;(11):CD010628.

94.  Reuber M, Burness C, Howlett S, et al. Tailored psychotherapy for patients with functional neurological symptoms: a pilot study. J Psychosom Res. 2007;63:625-632.

95.  Prigatano GP, Stonnington CM, Fisher RS. Psychological factors in the genesis and management of nonepileptic seizures: clinical observations. Epilepsy Behav. 2002;3:343-349.

96.  Drake ME Jr, Pakalnis A, Phillips BB. Neuropsychological and psychiatric correlates of intractable pseudoseizures. Seizure. 1992;1:11-13.

97.  Marazziti D, Dell'Osso B. Effectiveness of risperidone in psychogenic stiff neck. CNS Spectr. 2005;10:443-444.

98.  Persinger MA. Seizure suggestibility may not be an exclusive differential indicator between psychogenic and partial complex seizures: the presence of a third factor. Seizure. 1994;3:215-219.

99.  Dabholkar PD. Use of ECT in hysterical catatonia: a case report and discussion. Br J Psychiatry. 1988;153:246-247.

100.  Daniel WF, Crovitz HF. ECT-induced alteration of psychogenic amnesia. Acta Psychiatr Scand. 1986;74:302-303.

101.  Edwards JG. Electroconvulsive therapy in the treatment of bizarre psychogenic movements. Br J Psychiatry. 1969;115:1065-1067.

102.  Chastan N, Parain D, Verin E, et al. Psychogenic aphonia: spectacular recovery after motor cortex transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry. 2009;80:94.

103.  Geraldes R, Coelho M, Rosa MM, et al. Abnormal transcranial magnetic stimulation in a patient with presumed psychogenic paralysis. J Neurol Neurosurg Psychiatry. 2008;79:1412-1413.

104.  Schonfeldt-Lecuona C, Connemann BJ, Spitzer M, et al. Transcranial magnetic stimulation in the reversal of motor conversion disorder. Psychother Psychosom. 2003;72:286-288.

105.  Smith GR Jr, Monson RA, Ray DC. Psychiatric consultation in somatization disorder: a randomized controlled study. N Engl J Med. 1986;314:1407-1413.

106.  Hoedeman R, Blankenstein AH, van der Feltz-Cornelis CM, et al. Consultation letters for medically unexplained physical symptoms in primary care. Cochrane Database Syst Rev. 2010;(12):CD006524.

107.  Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369:946-955.

108.  Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med. 2007;69:889-900.

109.  Bernardy K, Füber N, Köllner V, et al. Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome: a systematic review and metaanalysis of randomized controlled trials. J Rheumatol. 2010;37:1991-2005.

110.  Allen LA, Woolfolk RL, Escobar JI, et al. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med. 2006;166:1512-1518.

111.  Poole NA, Wuerz A, Agrawal N. Abreaction for conversion disorder: systematic review with meta-analysis. Br J Psychiatry. 2010;197:91-95.

112.  Rosen AC, Ramkumar M, Nguyen T, et al. Noninvasive transcranial brain stimulation and pain. Curr Pain Headache Rep. 2009;13:12-17.

113.  Grisaru N, Amir M, Cohen H, et al. Effect of transcranial magnetic stimulation in posttraumatic stress disorder: a preliminary study. Biol Psychiatry. 1998;44:52-55.

114.  Hafeiz HB. Hysterical conversion: a prognostic study. Br J Psychiatry. 1980;136:548-551.

115.  Robins LN, Regier DA, eds. Psychiatric disorders in America. New York, NY: Free Press; 1991:220-257.

116.  Bass CM, Murphy MR. Somatization disorder: critique of the concept and suggestions for future research. In: Bass CM, ed. Somatization: physical symptoms and psychological illness. Oxford, UK: Blackwell; 1990.

117.  Zwaigenbaum L, Szatmari P, Boyle MH, et al. Highly somatizing young adolescents and the risk of depression. Pediatrics. 1999;103:1203-1209.

118.  Williams C, Smith S, Sharpe M, et al. Overcoming functional neurological symptoms: a five areas approach. Boca Raton, FL: CRC Press; 2011.

使用此内容应接受我们的免责声明